Financial Disclosure

San Jose, Calif. – September 26, 2026 -- Overlord Labs, Inc. has closed an oversubscribed Seed round, lifting total funding to $10 million as the fabless semiconductor company moves its GENESIS Battery Intelligence IC from tape-out into product validation.

Seed extension totals $4.35 million led by Band of Angels

The financing comprises $7.25 million in Seed capital and the remainder in non-dilutive strategic development funding. The $4.35 million extension was led by Band of Angels, with participation from Foothill Ventures, Unlock Pacific Ventures, NuFund Venture Group, Sand Hill Angels and Castle Fund, alongside returning angel investors from earlier rounds.

Toronto – September 26, 2026 -- PomeGran Inc. has been named the #1 Telecom Services provider for the second consecutive year in The Globe and Mail's Report on Business magazine 2026 ranking of Canada's Top Growing Companies, placing #82 out of 375 companies nationwide on verified three-year revenue growth of 348% between 2022 and 2025.

PomeGran repeats as Canada's top-ranked telecom growth company

The Toronto-based fibre infrastructure provider previously ranked #62 overall among 400 companies in 2025, with three-year revenue growth of 557%. The company is listed in the ranking's Technology and Telecom category, based on its expansion of sovereign fibre networks and neocloud services across Ontario and Quebec.

Fort Worth, Texas – – September 25, 2026 -- Crescent Real Estate LLC has closed the sale of The Hotel at Avalon, a 330-room luxury property in Alpharetta, Georgia, marking one of the most notable hotel transactions in the Atlanta market in recent years.

Crescent acquired the property in September 2020 during peak pandemic uncertainty

The firm bought the hotel amid what it called "unprecedented uncertainty" in the hospitality sector, betting on the long-term strength of the asset despite widespread investor caution at the time. Christopher Goff, Senior Managing Director and Head of Capital Formation at Crescent, said the firm acquired the property at a basis reflecting that period of extraordinary market disruption.

San Mateo, Calif. – September 25, 2026 -- Kali Therapeutics has been named one of the 11 most promising private biotechnology companies in the 2026 Endpoints 11, a list curated annually by Endpoints News editors from hundreds of private candidates.

Kali advanced two clinical candidates and closed a Sanofi licensing deal in just over two years

Founded in July 2024, the clinical-stage biotech moved from formation to two molecules in the clinic and a worldwide partnership with Sanofi inside roughly two years. The honorees were announced Thursday, September 24, 2026, at an awards gala at The State Room in Boston.

Tokyo – September 25, 2026 -- LEIFRAS Co., Ltd. (Nasdaq: LFS) has secured new contracts with five Japanese municipalities to manage the regional transition of school club activities, expanding its footprint in an estimated JPY500 billion domestic market as the country's teacher work-style reform enters what officials call the "Reform Implementation Period" in fiscal 2026.

London – – September 25, 2026 -- Nscale Limited has closed a $3.36 billion convertible loan note financing led by Third Point, with NVIDIA committing an additional $1 billion tranche expected to fund in mid-November 2026.

Nscale secures $2.36 billion at initial closing, with NVIDIA's $1 billion tranche to follow

The financing structure splits into two tranches: a $2.36 billion initial close and a subsequent $1 billion commitment from NVIDIA. Goldman Sachs & Co. LLC acted as placement agent for the round.

Hollywood, Fla. – September 25, 2026 -- The South Broward Hospital District Board of Commissioners has unanimously voted to maintain its millage rate at 0.0805, the lowest level in the district's recorded history, even as Memorial Healthcare System expands facilities and services across South Florida.

Board keeps tax rate unchanged after 15 years of cuts

The 0.0805 rate was first set in 2025 following 15 consecutive years of millage rate reductions. The decision to hold the rate steady comes despite rising healthcare costs and broader industry cost pressures facing hospital systems.

"Maintaining the lowest tax rate in the district's history reflects our commitment to being responsible with taxpayer dollars," said Elizabeth Justen, chair of the South Broward Hospital District Board of Commissioners.

Bad Homburg, Germany – September 25, 2026 -- Fresenius Medical Care will exit its peritoneal dialysis business in China and discontinue local production and sales of its 4008A hemodialysis system, triggering one-time costs of approximately €110 million in the third quarter of 2026.

The charge, tied to impairment, scrappage and termination costs, will be treated as a special item and is not expected to meaningfully affect the future revenue outlook for the China business within the Company's Care Enablement segment.

China accounts for 6-7% of Care Enablement segment revenue

Fresenius Medical Care has operated in China for more than two decades, a market the Company says offers long-term growth tied to rising chronic kidney disease prevalence and expanding dialysis care.

Uppsala – September 25, 2026 -- Nanexa AB has signed a global exclusive license and collaboration agreement with Novo Nordisk worth up to EUR 1.165 billion, granting the Danish pharmaceutical giant rights to the Swedish company's PharmaShell atomic layer deposition (ALD) drug delivery platform for peptide-based treatments in obesity, type 2 diabetes and other cardiometabolic diseases.

Novo Nordisk gains rights to up to five development programs under the deal

The agreement covers formulations targeting monthly and quarterly administration frequencies, reducing dosing burden for chronic metabolic and cardiovascular disease patients. Novo Nordisk will lead global development and commercialization across all programs, while Nanexa retains eligibility for milestone-based payments tied to development, regulatory and sales achievements.

Waterloo, ON – September 25, 2026 -- OpenText Corporation (NASDAQ: OTEX; TSX: OTEX) has slashed the ceiling on its cash tender offer for outstanding 3.875% Senior Notes due 2028 to $300 million from $450 million, while pushing back key deadlines by one day.

OpenText lowers aggregate maximum tender amount by $150 million

The amended terms cut the Aggregate Maximum Tender Amount for the Bonds from $450 million to $300 million aggregate principal amount, according to the company's announcement modifying the Offer to Purchase dated September 23, 2026.